DXB 1.64% 30.0¢ dimerix limited

Ann: CFO and Company Secretary Appointment/Resignation, page-17

  1. 11,411 Posts.
    lightbulb Created with Sketch. 5727
    I also believe DXB will be a T/O target , Kathy was strong on announcing "several interested parties in the Technology" "Discussions had taken place with interested parties,,, I feel positive interested parties will move quickly to negotiate a price as they wont want the MC and value of DXB to run wild.. increasing their investment required to take over.

    Downsizing of staff and cleaning up the Share Registrar last year is usually a tell tale sign someone is coming to have a looksee,,, Once the Technology is verified with Positive Phase II results , much larger players have stronger abilities to bring to market fruition.. Sanofi would be my prime candidate being the owner of Irbesartan...

    The Trials should have been engineered with updates,,, long and arduous wait watching the SP erode???
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.005(1.64%)
Mkt cap ! $164.5M
Open High Low Value Volume
31.0¢ 31.0¢ 30.0¢ $818.6K 2.683M

Buyers (Bids)

No. Vol. Price($)
15 1874183 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10850 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
30.0¢
  Change
-0.005 ( 1.64 %)
Open High Low Volume
31.0¢ 31.0¢ 30.0¢ 640607
Last updated 15.54pm 28/03/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.